Research Corporation Technologies, Inc
Research Corporation Technologies (RCT) is a Tucson-based life‑science commercialization and early‑stage investment organization. RCT operates RCT Ventures, a program that provides venture capital to start‑up and early‑stage biomedical and medical device companies, and licenses biomedical technologies (nonexclusive) developed or represented by RCT. The organization supports translation of life‑science inventions from concept to patent to commercial product and runs programming such as the MedTech Innovator competition to identify and support early‑stage medtech opportunities.
Services
Venture capital funding
RCT Ventures provides venture capital to start‑up and early‑stage biomedical and medical device companies and participates in financings (examples on the site include seed/early rounds and later rounds led or supported by RCT).
Technology licensing
Nonexclusive licensing of RCT‑developed or represented life sciences technologies (tools, platforms, biologics and devices).
Technology development and translational support
Development and advancement of biomedical technologies toward commercial readiness (concept → patent → product).
Entrepreneur support and competitions (MedTech Innovator)
Organization and sponsorship of a medtech competition (MedTech Innovator) that provides cash prizes, partner resources, and exposure to investors and industry partners.
Partnerships and industry collaborations
Formation of research, development and commercial partnerships (examples on site include partnerships for expression systems, glycoprotein production and platform licensing).
Venture capital funding
RCT Ventures provides venture capital to start‑up and early‑stage biomedical and medical device companies and participates in financings (examples on the site include seed/early rounds and later rounds led or supported by RCT).
Technology licensing
Nonexclusive licensing of RCT‑developed or represented life sciences technologies (tools, platforms, biologics and devices).
Technology development and translational support
Development and advancement of biomedical technologies toward commercial readiness (concept → patent → product).
Entrepreneur support and competitions (MedTech Innovator)
Organization and sponsorship of a medtech competition (MedTech Innovator) that provides cash prizes, partner resources, and exposure to investors and industry partners.
Partnerships and industry collaborations
Formation of research, development and commercial partnerships (examples on site include partnerships for expression systems, glycoprotein production and platform licensing).
Portfolio
Winner of the 2014 MedTech Innovator competition produced by RCT Ventures.
#Medical device / tissue engineering
MedTech Idol / competition winner referenced in RCT coverage.
#Medical device (in‑office ear tube placement)
Reported completion of a $15M financing round supporting product launch and expansion.
#Orthopedics / surgical navigation
RCT led or supported financing rounds (site references $10M, later $12M led by RCT) and clinical program activity.
#Therapeutics / drug formulation (DST-0509 referenced)
Multiple Series B financings reported on the site (2018, 2019, 2020).
#Biotech / manufacturing and market entry (company raising Series B)
Reported $9M Series B to expand product portfolio (viral whole genome sequencing applications also mentioned).
#Genomics / library preparation and sequencing reagents
Winner of the 2014 MedTech Innovator competition produced by RCT Ventures.
#Medical device / tissue engineering
MedTech Idol / competition winner referenced in RCT coverage.
#Medical device (in‑office ear tube placement)
Reported completion of a $15M financing round supporting product launch and expansion.
#Orthopedics / surgical navigation
RCT led or supported financing rounds (site references $10M, later $12M led by RCT) and clinical program activity.
#Therapeutics / drug formulation (DST-0509 referenced)
Multiple Series B financings reported on the site (2018, 2019, 2020).
#Biotech / manufacturing and market entry (company raising Series B)
Reported $9M Series B to expand product portfolio (viral whole genome sequencing applications also mentioned).
#Genomics / library preparation and sequencing reagents